Prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients at Northwest Amhara Comprehensive Specialized Hospitals, Northwest Ethiopia 2021

Abstract

Introduction The worldwide prevalence of Diabetic Retinopathy was recently estimated to be 34.6%. The prevalence of diabetic retinopathy in developed nations has been thoroughly investigated, and risk factors are well understood. However, there is a shortage of information in the study areas about the prevalence and contributing factors of diabetic retinopathy among type two diabetes patients. Objective The aim of this study was to assess the prevalence of diabetic retinopathy and associated factor among type 2 diabetic patients who were on follow up services at northwest Amhara comprehensive specialized hospitals diabetic care units. Method An institutional based cross-sectional study was conducted at northwest Amhara comprehensive specialized hospitals from October 15 to November 15, 2021, among 496 diabetes patients. Systematic random sampling technique was used. Data were collected by utilizing a semi-structured questionnaire and a direct Topcon retinal camera inspection. Then data were coded, entered, and exported to SPSS version 23 from EPI-Data version 4.6. All variables with P-value < 0.25 in the binary logistic regression analyses were included in the multivariable regression analysis. The degree of association was interpreted by using the adjusted odds ratio with 95% confidence intervals, and the significance level was declared at P-value < 0.05. The Hosmer–Lemeshow test was used to check the fitness of the model. Result The prevalence of diabetic retinopathy among type two diabetes patients was 36.3%. Sex [AOR = 3.25, 95% CI (1.80, 6.68)], visiting health institution [AOR = 0.027, 95% CI (0.003, 0.253)], educational level [AOR = 4.23, 95% CI (1.09, 16.47)], glycemic control [AOR = 0.099, 95% CI (0.02, 0.49)], hypertension status (AOR = 2.56, 95% CI (1.01, 6.45)] were significantly associated with diabetic retinopathy. Conclusion In this study less than half of diabetic patients had diabetic retinopathy. Sex, visiting health institution, educational level, glycemic control, and hypertension status were significantly associated with diabetic retinopathy.

The Value of White Cell Inflammatory Biomarkers as Potential Predictors for Diabetic Retinopathy in Type 2 Diabetes Mellitus (T2DM)

“…Despite significant achievements in early diagnosis and therapy, diabetic retinopathy is currently the major cause of blindness and visual impairment in working-age adults worldwide [ 2 ], causing an increased burden on national healthcare systems worldwide [ 3 ]. The prevalence of diabetic retinopathy is estimated to be 27.0% in diabetic patients, which leads to 0.4 million incidences of blindness in the world [ 4 ]. The World Health Organization (WHO) Universal Eye Health: A Global Action Plan 2014–2019 outlines the need to achieve a reduction in the prevalence of avoidable visual impairment and blindness, including that related to diabetes, which is currently among the five most common causes of both moderate or severe visual impairment and blindness [ 5 ].…”

Early detection of peripheral neuropathy and its correlation with retinopathy and HbA1c levels in type 2 diabetes mellitus patients

“…The prevalence of diabetic retinopathy in our study was 18.1% (95% CI: 11.9-26.5) similar to the prevalence of DR reported by Sivaprasad S et al 16 which had 17.4% (95% CI 15.1%, 19.7%). In another study by Zegeye AF et al, 17 the prevalence was high at 36.3% (95% CI:29.8-47.6).…”

A multidomain bio-inspired feature extraction and selection model for diabetic retinopathy severity classification: an ensemble learning approach

“…Numerous statistical studies conducted across the globe reveal the fact that diabetic retinopathy has acted as a significant public health issue in the present society. As per the data of 2023, the prevalence of diabetic retinopathy is estimated to be 34.6% 1 . The 74th World Health Organization (WHO) study revealed that more than 420 million people had diabetes in 2021, and 578 million were predicted to have the disease by 2030.…”